Literature DB >> 11168782

Substance P: a pioneer amongst neuropeptides.

T Hökfelt1, B Pernow, J Wahren.   

Abstract

A brief overview of recent developments in the substance P field is provided, in addition to a historical introduction. It is emphasized that there are multiple tachykinins and tachykinin receptors and that there are examples of coexistence of several tachykinin peptides and of several tachykinin receptors in single cells, and there is evidence for tachykininergic cotransmission. The distribution and functional significance of tachykinins in the gastrointestinal tract and in sensory neurones, and interactions with other peptides and transmitters, are reviewed. The recent production of knock-out mice for either substance P or the NK1 receptor is discussed, as well as the exciting concept of substance P receptor internalization. Finally, the development of specific substance P antagonists is summarized, and possible clinical implications discussed, and, in particular, a recent study which reports that a substance P antagonist shows clinical efficacy in depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168782     DOI: 10.1046/j.0954-6820.2000.00773.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  78 in total

1.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

2.  Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.

Authors:  Nancy Walters; Theresa Trunkle; Michael Sura; David W Pascual
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

Review 4.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

5.  Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Authors:  Alexandra Taracanova; Irene Tsilioni; Pio Conti; Errol R Norwitz; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-19       Impact factor: 11.205

6.  Thioamide Substitution Selectively Modulates Proteolysis and Receptor Activity of Therapeutic Peptide Hormones.

Authors:  Xing Chen; Elizabeth G Mietlicki-Baase; Taylor M Barrett; Lauren E McGrath; Kieran Koch-Laskowski; John J Ferrie; Matthew R Hayes; E James Petersson
Journal:  J Am Chem Soc       Date:  2017-11-13       Impact factor: 15.419

Review 7.  Inflammation in acute CNS injury: a focus on the role of substance P.

Authors:  F Corrigan; R Vink; R J Turner
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

8.  bHLH proneural genes as cell fate determinants of entero-endocrine cells, an evolutionarily conserved lineage sharing a common root with sensory neurons.

Authors:  Volker Hartenstein; Shigeo Takashima; Parvana Hartenstein; Samuel Asanad; Kian Asanad
Journal:  Dev Biol       Date:  2017-07-24       Impact factor: 3.582

9.  Ethanol inhibits the binding of substance P to rat brain cortex NK1 receptors.

Authors:  S Scarrone; A Cappelli; A Cupello; M Matarrese; R M Moresco; F Fazio
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

10.  The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.

Authors:  Miguel Muñoz; Marisa Rosso
Journal:  Invest New Drugs       Date:  2009-01-17       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.